Danaher Corporation (DHR)
NYSE: DHR · IEX Real-Time Price · USD
265.80
+0.96 (0.36%)
At close: May 17, 2024, 4:00 PM
266.68
+0.88 (0.33%)
Pre-market: May 20, 2024, 8:05 AM EDT
Danaher Market Cap
Danaher has a market cap or net worth of $196.87 billion as of May 20, 2024. Its market cap has increased by 15.59% in one year.
Market Cap
196.87B
Enterprise Value
208.01B
1-Year Change
15.59%
Ranking
Category
Stock Price
$265.80
Market Cap Chart
Since December 1, 1998, Danaher's market cap has increased from $6.13B to $196.87B, an increase of 3,114.07%. That is a compound annual growth rate of 14.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 196.87B | 0.36% |
May 16, 2024 | 196.16B | 0.52% |
May 15, 2024 | 195.14B | 1.62% |
May 14, 2024 | 192.03B | 3.04% |
May 13, 2024 | 186.36B | -0.70% |
May 10, 2024 | 187.68B | 0.78% |
May 9, 2024 | 186.23B | 0.75% |
May 8, 2024 | 184.84B | 0.32% |
May 7, 2024 | 184.25B | 0.55% |
May 6, 2024 | 183.25B | -0.39% |
May 3, 2024 | 183.97B | 0.62% |
May 2, 2024 | 182.83B | -0.02% |
May 1, 2024 | 182.87B | 0.11% |
Apr 30, 2024 | 182.67B | -0.08% |
Apr 29, 2024 | 182.82B | 0.10% |
Apr 26, 2024 | 182.64B | 0.32% |
Apr 25, 2024 | 182.06B | -1.84% |
Apr 24, 2024 | 185.48B | -1.07% |
Apr 23, 2024 | 187.48B | 7.36% |
Apr 22, 2024 | 174.63B | 0.24% |
Apr 19, 2024 | 174.21B | -0.36% |
Apr 18, 2024 | 174.84B | -1.27% |
Apr 17, 2024 | 177.08B | -0.40% |
Apr 16, 2024 | 177.78B | 0.28% |
Apr 15, 2024 | 177.28B | -0.12% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Merck & Co. | 332.08B |
AbbVie | 293.68B |
AstraZeneca | 238.44B |
Thermo Fisher | 226.90B |
Novartis AG | 200.81B |
Abbott Laboratories | 181.10B |
Amgen | 167.32B |
Pfizer | 162.15B |